Cargando…
Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8(+) T Lymphocytes in Ovarian Carcinosarcoma
Ovarian carcinosarcoma (OCS) accounts for high mortality and lacks effective therapeutic methods. So far, we lack reliable biomarkers capable of predicting the risk of aggressive course of the disease. Programmed death ligand-1 (PD-L1) is expressed in various tumors, and antibodies targeting its rec...
Autores principales: | Zhu, Jun, Wen, Hao, Ju, Xingzhu, Bi, Rui, Zuo, Wenjia, Wu, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268655/ https://www.ncbi.nlm.nih.gov/pubmed/28125702 http://dx.doi.org/10.1371/journal.pone.0170879 |
Ejemplares similares
-
Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer
por: Feng, Zheng, et al.
Publicado: (2016) -
Programmed death ligand 1 and tumor-infiltrating CD8(+) T lymphocytes are associated with the clinical features in meningioma
por: Zhang, Yaochuan, et al.
Publicado: (2022) -
Ovarian Carcinosarcoma and Response to Immunotherapy
por: Daniyal, Muhammad, et al.
Publicado: (2023) -
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer
por: Huang, Chih-Yang, et al.
Publicado: (2018) -
Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma
por: Wang, Wen-Peng, et al.
Publicado: (2018)